| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M002095200 |
| P698 | PubMed publication ID | 10887202 |
| P2093 | author name string | S. Ross | |
| T. Burgess | |||
| B. D. Bennett | |||
| M. Haniu | |||
| P. Denis | |||
| S. Kahn | |||
| M. Citron | |||
| J. Fuller | |||
| G. Rogers | |||
| V. Katta | |||
| Y. Young | |||
| R. Vassar | |||
| J. O. Hui | |||
| E. A. Mendiaz | |||
| P2860 | cites work | Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity | Q22010912 |
| Purification and cloning of amyloid precursor protein beta-secretase from human brain | Q22010914 | ||
| P433 | issue | 28 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 21099–21106 | |
| P577 | publication date | 2000-07-14 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties | |
| P478 | volume | 275 |
| Q40859157 | A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's beta -secretase |
| Q31816631 | A splice variant of beta-secretase deficient in the amyloidogenic processing of the amyloid precursor protein |
| Q34072320 | Abeta-generating enzymes: recent advances in beta- and gamma-secretase research |
| Q36515891 | Activation of protein kinase C modulates BACE1-mediated beta-secretase activity |
| Q28477836 | Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging |
| Q36016766 | Alzheimer's disease beta-secretase BACE1 is not a neuron-specific enzyme |
| Q34566551 | Amyloid metabolism and secretases in Alzheimer's disease |
| Q34208401 | Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease |
| Q53240567 | Amyloid precursor protein beta-secretase (BACE) mRNA expression in human neural cell lines following induction of neuronal differentiation and exposure to cytokines and growth factors. |
| Q38493207 | Application of a Bioinformatics-Based Approach to Identify Novel Putative in vivo BACE1 Substrates |
| Q31123558 | Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent |
| Q34156758 | BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease |
| Q38120669 | BACE1 as a therapeutic target in Alzheimer's disease: rationale and current status |
| Q35809329 | BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice |
| Q32063781 | BACE1 is the major beta-secretase for generation of Abeta peptides by neurons |
| Q33202614 | BACE1: the beta-secretase enzyme in Alzheimer's disease |
| Q30749785 | Beta-secretase (BACE) as a drug target for Alzheimer's disease |
| Q37866692 | Beta-secretase as a target for Alzheimer's disease drug discovery: an overview of in vitro methods for characterization of inhibitors |
| Q34976280 | Beta-secretase as a target for the treatment of Alzheimer's disease |
| Q34066765 | Beta-secretase: structure, function, and evolution |
| Q37210063 | Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease |
| Q48217048 | Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis |
| Q37416750 | Cell biology, regulation and inhibition of beta-secretase (BACE-1). |
| Q30661499 | Characterization of the glycosylation profiles of Alzheimer's beta -secretase protein Asp-2 expressed in a variety of cell lines. |
| Q94464057 | Circulating Exosomal miRNA as Diagnostic Biomarkers of Neurodegenerative Diseases |
| Q34286933 | Closing in on the amyloid cascade: recent insights into the cell biology of Alzheimer's disease |
| Q40672238 | Comparative studies of active site-ligand interactions among various recombinant constructs of human beta-amyloid precursor protein cleaving enzyme |
| Q97570180 | Critical analysis of the use of β-site amyloid precursor protein-cleaving enzyme 1 inhibitors in the treatment of Alzheimer's disease |
| Q54111592 | Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models. |
| Q35019434 | Emerging Alzheimer's disease therapies: inhibition of beta-secretase |
| Q40674796 | Endoproteolysis of beta-secretase (beta-site amyloid precursor protein-cleaving enzyme) within its catalytic domain. A potential mechanism for regulation |
| Q28214776 | Endosomal proteolysis of internalized insulin at the C-terminal region of the B chain by cathepsin D |
| Q46818675 | Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis. |
| Q34158282 | Enzymic properties of recombinant BACE2. |
| Q42049875 | Failure of the interaction between presenilin 1 and the substrate of gamma-secretase to produce Abeta in insect cells |
| Q33862796 | Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects |
| Q48345479 | GGA1 is expressed in the human brain and affects the generation of amyloid beta-peptide. |
| Q40537045 | Human BACE forms dimers and colocalizes with APP. |
| Q37961866 | Identification and biology of β-secretase |
| Q40684851 | Identification of a beta-secretase activity, which truncates amyloid beta-peptide after its presenilin-dependent generation |
| Q34080500 | In search of an enzyme: the beta-secretase of Alzheimer's disease is an aspartic proteinase |
| Q36869427 | Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease |
| Q34007475 | Inhibition of BACE1 for therapeutic use in Alzheimer's disease |
| Q40545312 | Internalization of exogenously added memapsin 2 (beta-secretase) ectodomain by cells is mediated by amyloid precursor protein |
| Q37915426 | Intracellular trafficking of the β-secretase and processing of amyloid precursor protein |
| Q37781814 | Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions |
| Q37544756 | Mechanism-based treatments for Alzheimer's disease |
| Q36023269 | Membrane proteases in the bacterial protein secretion and quality control pathway |
| Q52655365 | Membrane-association of EMR2/ADGRE2-NTF is regulated by site-specific N-glycosylation. |
| Q40014779 | NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42. |
| Q30674796 | Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology |
| Q34180114 | Neurotoxic traffic: uncovering the mechanics of amyloid production in Alzheimer's disease |
| Q24292718 | PAR-4 is involved in regulation of beta-secretase cleavage of the Alzheimer amyloid precursor protein |
| Q28214125 | Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer's disease |
| Q35009345 | Pharmacogenomics for the treatment of dementia |
| Q30486959 | Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis |
| Q33575863 | Physiological Functions of the β-Site Amyloid Precursor Protein Cleaving Enzyme 1 and 2 |
| Q24803627 | Pro-domain removal in ASP-2 and the cleavage of the amyloid precursor are influenced by pH |
| Q34110227 | Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process |
| Q30494468 | Rapid and direct transport of cell surface APP to the lysosome defines a novel selective pathway |
| Q40629788 | Recombinant insect cell expression and purification of human beta-secretase (BACE-1) for X-ray crystallography |
| Q34061109 | Regulation of APP cleavage by alpha-, beta- and gamma-secretases |
| Q37961881 | Regulation of β-site APP-cleaving enzyme 1 gene expression and its role in Alzheimer's disease |
| Q89287870 | Resveratrol Induces Brain Resilience Against Alzheimer Neurodegeneration Through Proteostasis Enhancement |
| Q28202553 | Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory |
| Q57278508 | Sequential Virtual Screening Approach to the Identification of Small Organic Molecules as Potential BACE-1 Inhibitors |
| Q38059094 | Splice variants of the Alzheimer's disease beta-secretase, BACE1. |
| Q28363447 | Spotlight on BACE: the secretases as targets for treatment in Alzheimer disease |
| Q37030825 | Structure-activity relationship of memapsin 2: implications on physiological functions and Alzheimer's disease |
| Q31032457 | Substrate and inhibitor profile of BACE (beta-secretase) and comparison with other mammalian aspartic proteases |
| Q36397690 | The Alzheimer's disease beta-secretase enzyme, BACE1. |
| Q37108142 | The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease |
| Q37987919 | The Membrane-Bound Aspartyl Protease BACE1: Molecular and Functional Properties in Alzheimer's Disease and Beyond |
| Q37614747 | The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential |
| Q32061148 | The beta-secretase, BACE: a prime drug target for Alzheimer's disease |
| Q34398091 | The cell biology of Alzheimer's disease: uncovering the secrets of secretases |
| Q35570991 | The effect of HIV protease inhibitors on amyloid-β peptide degradation and synthesis in human cells and Alzheimer's disease animal model |
| Q33722837 | The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. |
| Q28610071 | The normal and pathologic roles of the Alzheimer's β-secretase, BACE1 |
| Q43510103 | The protease inhibitor, MG132, blocks maturation of the amyloid precursor protein Swedish mutant preventing cleavage by beta-Secretase |
| Q37225050 | The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology |
| Q38127826 | The structural evolution of β-secretase inhibitors: a focus on the development of small-molecule inhibitors |
| Q90730208 | The β-Secretase BACE1 in Alzheimer's Disease |
| Q37884646 | The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease |
| Q43715378 | Three novel alternatively spliced isoforms of the human beta-site amyloid precursor protein cleaving enzyme (BACE) and their effect on amyloid beta-peptide production |
| Q26825722 | Trafficking regulation of proteins in Alzheimer's disease |
| Q38062499 | Transcriptional and post-transcriptional regulation of β-secretase. |
| Q40581861 | Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. |
| Q46175385 | Upregulation of BACE1 and beta-amyloid protein mediated by chronic cerebral hypoperfusion contributes to cognitive impairment and pathogenesis of Alzheimer's disease |
| Q35140078 | gamma-Secretase inhibitors--from molecular probes to new therapeutics? |
| Q38785698 | miR-124 Regulates the Expression of BACE1 in the Hippocampus Under Chronic Cerebral Hypoperfusion |
| Q64892700 | pHluorin-BACE1-mCherry Acts as a Reporter for the Intracellular Distribution of Active BACE1 In Vitro and In Vivo. |
| Q34240868 | Β-site APP-cleaving enzyme 1 trafficking and Alzheimer's disease pathogenesis |
| Q36951145 | β-Secretase: its biology as a therapeutic target in diseases |
Search more.